Mitralign Investors

29 investors on Angel Roster list Mitralign in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the Netherlands, the United States and the United Kingdom.

Investors are matched on the company name in their portfolio, so companies that share the name Mitralign can appear together.

Investors listed
29
With verified email
28%
Most common stage
Seed
Top location
Netherlands

Updated October 13, 2026 · How we compile this data

Top 29 Mitralign investors

The most complete profiles first. Showing 29 of 29.

  • Antoine BoulangerVerified

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Verified email available

  • Nisa LeungVerified

    Venture Capital, Private Equity Firm, Investment Partner · United States

    Series BSeries AHealth CareHospitalsAutonomous VehiclesComputer Vision

    Portfolio: Saints Sages Medical, Berry Genomics, DiNovA Medtech, Broncus Technologies and 119 more

    Verified email available

  • Anastasia KarpovaVerified

    Venture Capital · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Verified email available

  • David QuinlivanVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWearablesTelecommunicationsE-commerce

    Portfolio: Direct Flow Medical, Envivio, Broncus Technologies, Cianna Medical and 44 more

    Verified email available

  • John MontanaVerified

    Venture Capital, Private Equity Firm, Investment Partner · United Kingdom

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Verified email available

  • Marian NakadaVerified

    Venture Capital, Corporate Venture Capital · United States

    Health CareWearablesWellnessWomen Founded

    Portfolio: Catalyst Biosciences, Cardiac Dimensions, CoStim Pharmaceuticals, CoAxia and 58 more

    Verified email available

  • Vijay MurthyVerified

    Venture Capital, Corporate Venture Capital · United States

    Health CareWearablesWellnessWomen Founded

    Portfolio: Catalyst Biosciences, Cardiac Dimensions, CoStim Pharmaceuticals, CoAxia and 58 more

    Verified email available

  • Asish Xavier

    Venture Capital, Corporate Venture Capital, Investor · United States

    SeedHealth CareWearablesWellnessWomen Founded

    Portfolio: Catalyst Biosciences, Cardiac Dimensions, CoStim Pharmaceuticals, CoAxia and 58 more

    Contact details available

  • Geert

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Holger Reithinger

    Venture Capital, Investor · Germany

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 64 more

    Contact details available

  • Jeanne Bolger

    Venture Capital, Corporate Venture Capital, Investor · United Kingdom

    Series AHealth CareWearablesWellnessWomen Founded

    Portfolio: Catalyst Biosciences, Cardiac Dimensions, CoStim Pharmaceuticals, CoAxia and 58 more

    Contact details available

  • Juliette Audet

    Venture Capital, Investor · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Martien van Osch

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 64 more

    Contact details available

  • Rogier Rooswinkel

    Venture Capital, Investor · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Wouter Joustra

    Venture Capital, Investor · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Maurice BronckersVerified

    Venture Capital, Private Equity Firm · Netherlands

    Health CareInvestment ManagementInfrastructureApps

    Portfolio: Exie, Mitralign, Savaco, Yellowbrix and 4 more

    Verified email available

  • Asiya Giniatullina

    Venture Capital · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Bob Keppler

    Venture Capital, Private Equity Firm · United States

    Health CareWearablesTelecommunicationsE-commerce

    Portfolio: Direct Flow Medical, Envivio, Broncus Technologies, Cianna Medical and 44 more

    Contact details available

  • Bonnie van Wilgenburg

    Venture Capital · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Carlo Incerti

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Leslie Montag

    Venture Capital · United States

    Health CareWearablesTelecommunicationsE-commerce

    Portfolio: Direct Flow Medical, Envivio, Broncus Technologies, Cianna Medical and 44 more

    Contact details available

  • Sander van Deventer

    Venture Capital · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Suzette Dutch

    Venture Capital · United States

    Health CareTelecommunicationsLife ScienceElectrical Distribution

    Portfolio: Hydrocision, Celleration, Kereos, CoLucid Pharmaceuticals and 10 more

    Contact details available

  • Vincent van Houten

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Bert

    Venture Capital, Private Equity Firm · Netherlands

    Health CareInvestment ManagementInfrastructureApps

    Portfolio: Exie, Mitralign, Savaco, Yellowbrix and 4 more

    Contact details available

  • Marc Staal

    Venture Capital, Private Equity Firm · Netherlands

    Health CareInvestment ManagementInfrastructureApps

    Portfolio: Exie, Mitralign, Savaco, Yellowbrix and 4 more

    Contact details available

  • Paul Hugenholtz

    Venture Capital, Private Equity Firm · Netherlands

    Health CareInfrastructureAppsLighting

    Portfolio: Exie, Mitralign, Savaco, Yellowbrix and 4 more

    Contact details available

  • Paul van Steijn

    Venture Capital, Private Equity Firm · Netherlands

    Health CareInvestment ManagementInfrastructureApps

    Portfolio: Exie, Mitralign, Savaco, Yellowbrix and 4 more

    Contact details available

  • Sander de Lange

    Venture Capital, Private Equity Firm · Netherlands

    Health CareInfrastructureAppsLighting

    Portfolio: Exie, Mitralign, Savaco, Yellowbrix and 4 more

    Contact details available

Frequently asked questions

How many Mitralign investors are on Angel Roster?

Angel Roster lists 29 Mitralign investors. 8 of them (28%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (29), Private Equity Firms (15) and Investment Partner Investors (7). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Mitralign investors invest in?

Among those that list a stage, the most common are Seed (8), Series A (2) and Series B (1).

Where are Mitralign investors based?

Most are based in the Netherlands (18), the United States (8) and the United Kingdom (2).

Which companies have Mitralign investors backed?

The most-backed portfolio companies among them are Pieris AG (20), BioVex (15), Oxyrane UK (14), Catalym (14) and Cardoz (14).

How do I contact Mitralign investors?

Create a free Angel Roster account to search and filter all 29, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.